跳至主要内容
临床试验/NCT02192632
NCT02192632已完成不适用

Dermatologists' Educational Demonstration for Epiduo Application

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
85
试验地点
1
主要终点
Percentile reduction of non-inflammatory & inflammatory acne lesions

研究概览

简要总结

The purpose of this study is to evaluate the efficacy and tolerability of this combination gel compared with BPO monotherapy in Korean patients, and test clinical practicability of dermatologists' educational demonstration for how to apply this gel in reducing uncomfortable irritations.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • mild to moderate acne were evaluated by Leeds revised acne grade from 2 to 6
  • age: 18-40

排除标准

  • pregnancy
  • mental illness
  • intake of oral isotretinoin within 6 months
  • application of the other oral or topical acne medications
  • chemical peeling or light based treatments within 6 weeks.

研究组 & 干预措施

Epiduo- dermatologist's detailed instruction

Experimental

After randomly assigned to side of epiduo application, half of total patients were also re-assigned into detailed instruction for application of epiduo from dermatologist

干预措施: Epiduo once daily with detailed instruction for how to apply it (Drug)

Epiduo- drug insert only gruop

Experimental

After randomly assigned to side of epiduo application, half of total patients were also re-assigned into drug insert only group

干预措施: Epiduo- once daily, simple instruction for application (Drug)

BPO group

Placebo Comparator

After randomly assigned to side of BPO application, patients apply BPO during 12 week

干预措施: BPO once daily (Drug)

结局指标

主要结局

Percentile reduction of non-inflammatory & inflammatory acne lesions

时间窗: 12 weeks

Measurement of decreases in both non-inflammatory \& inflammatory acne lesions

次要结局

  • Total number of local irriation effect counts (erythema, scaling, dryness, itching)(12 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dae Hun Suh

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验